Recent developments in the field of diabetes treatment have introduced a revolutionary class of medications known as GLP-1 receptor agonists. These compounds work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that controls blood sugar levels. Among the most noteworthy GLP-1 receptor agonists are semaglut